Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 15 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Because demand from the medical and healthcare sectors and for industrial equipment remained firm, demand for small tuning-fork crystal units was resilient, and expanded sales of high-margin products, increased sales, improvement in the product mix, company-wide cost reductions, and initiatives focused on profitability contributed. The company expects to secure earnings in the second half through measures including further improvement in the product mix by expanding sales of high-margin products.
| Item | Details |
|---|---|
| Net Sales | ¥5,943 million → ¥6,648 million（+11.9%） |
| Operating profit | ¥84 million → ¥104 million（+24.2%） |
| Ordinary income | ¥23 million → ¥47 million（+99.0%） |
| Profit attributable to owners of the parent | ¥2 million → ¥12 million（+364.8%） |
| Net income per share | ¥0.33 / sen → ¥1.55 / sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 15 May 2026 |
| Previous-period results | Fiscal year ending March 2026: Revenue ¥5,784 million, operating loss ¥70 million, ordinary loss ¥54 million, net loss attributable to owners of the parent ¥12 million, net loss per share ¥1.48 |
| Reason for the revision | Because demand from the medical and healthcare sectors and for industrial equipment remained firm, demand for small tuning-fork crystal units was resilient, and expanded sales of high-margin products, increased sales, improvement in the product mix, company-wide cost reductions, and initiatives focused on profitability contributed. The company expects to secure earnings in the second half through measures including further improvement in the product mix by expanding sales of high-margin products. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue exceeded the forecast because demand from the medical and healthcare sectors and for industrial equipment remained firm, and demand for small tuning-fork crystal units was also resilient. On the earnings front, expanded sales of high-margin medical and healthcare products, increased sales of small tuning-fork crystal units, improvement in the product mix, company-wide cost reductions, and initiatives focused on profitability contributed.